(Q48280499)

10 February 2018

title

Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons. (English)

1 reference

10 February 2018

1 reference

2

1 reference

10 February 2018

Gloria Lazzeri

Gloria Lazzeri

1

0 references

Michela Ferrucci

Michela Ferrucci

4

0 references

Carla L Busceti

Carla L Busceti

3

0 references

Francesco Fornai

Francesco Fornai

8

0 references

author name string

Alessandra Falleni

5

1 reference

10 February 2018

Valeria Bruno

6

1 reference

10 February 2018

Antonio Paparelli

7

1 reference

10 February 2018

language of work or name

English

0 references

publication date

5 February 2007

1 reference

10 February 2018

Journal of Neurochemistry

published in

1 reference

10 February 2018

volume

101

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

1414-1427

1 reference

10 February 2018

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Neuronal cell death in Huntington's disease: a potential role for dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Dopamine covalently modifies and functionally inactivates parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04429.X

10.1111/J.1471-4159.2006.04429.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

17286589

1 reference

10 February 2018